A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according […]
A large review of opioid pain relievers prescribed for acute pain has found these medicines provide only small, short-term relief for some acute conditions and are ineffective for some others. The study set out to […]
A key goal in aging research is not just to extend life, but to ensure more people live longer and healthier lives with less variation in age at death, a concept known as “squaring the […]
A research team at Kumamoto University has discovered that a natural compound found in pomegranate leaves and branches can directly break down harmful protein aggregates linked to transthyretin (TTR) amyloidosis, a progressive and potentially life-threatening […]
When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don’t fight them—throw them in the cellular trash. In a new study published in Nature Communications, scientists developed protein-like polymers (PLPs) […]
Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in recent years. Despite its clinical success, its precise molecular and cellular mechanisms are still not […]
Many women who become pregnant while taking antidepressants face a difficult decision: Should they continue their medication to protect themselves against severe depression, or stop to avoid possible risks to the baby? New research from […]
Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and Drug Administration has announced that it will crack […]
New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model. The current standard treatment for preterm labor, […]
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the pharmaceutical industry has long considered unprofitable.This article was […]
© 2025 SimplyWell.ca